| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.34 | 0.03 |